Pages that link to "Q35076151"
Jump to navigation
Jump to search
The following pages link to Molecular cloning of human prostate specific antigen cDNA. (Q35076151):
Displaying 50 items.
- Full-length cDNA sequence and genomic organization of human NKX3A - alternative forms and regulation by both androgens and estrogens (Q24290690) (← links)
- Primary structure of a new actin-binding protein from human seminal plasma (Q24298371) (← links)
- Cloning and expression of human salivary-gland kallikrein in Escherichia coli (Q24528094) (← links)
- Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein (Q24561757) (← links)
- Twenty Years of PSA: From Prostate Antigen to Tumor Marker (Q24564782) (← links)
- A novel protease homolog differentially expressed in breast and ovarian cancer (Q24654651) (← links)
- Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap and TissueInfo databases (Q24794759) (← links)
- Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors (Q28208139) (← links)
- Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP (Q28242953) (← links)
- Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences (Q28243373) (← links)
- A comprehensive nomenclature for serine proteases with homology to tissue kallikreins (Q28248469) (← links)
- Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors (Q28267380) (← links)
- Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen (Q28285751) (← links)
- The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein (Q28303113) (← links)
- Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites (Q30309352) (← links)
- Androgen-repressed phenotype in human prostate cancer (Q30454285) (← links)
- Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer (Q30828173) (← links)
- Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein (Q30861009) (← links)
- Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry (Q31044291) (← links)
- Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms (Q31123489) (← links)
- Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes (Q31892738) (← links)
- A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium (Q33320106) (← links)
- Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms (Q33526707) (← links)
- Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen (Q34013817) (← links)
- The clinical impact of different assays for prostate specific antigen. (Q34022442) (← links)
- N-glycans of human protein C inhibitor: tissue-specific expression and function (Q34113685) (← links)
- Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. (Q34180952) (← links)
- Dendritic Cell‐Based Immunotherapy for Prostate Cancer (Q34284652) (← links)
- Prostate-specific Antigen and Human Glandular Kallikrein: Two Kallikreins of the Human Prostate (Q34292339) (← links)
- Prostate-specific antigen kallikrein and the heart (Q34390618) (← links)
- The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19. (Q34412912) (← links)
- Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy (Q34429991) (← links)
- The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease. (Q34447102) (← links)
- Separation methods applicable to prostate cancer diagnosis and monitoring therapy. (Q34510265) (← links)
- Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring (Q34810177) (← links)
- Molecular cloning and characterization of novel prostate antigen cDNA's (Q35104809) (← links)
- Biochemical staging of prostate cancer (Q35123256) (← links)
- Immunotherapy and prostate cancer (Q35145709) (← links)
- Analysis of prostate-specific antigen transcripts in chimpanzees, cynomolgus monkeys, baboons, and African green monkeys. (Q35147686) (← links)
- Prostate-specific antigen and diagnosing early malignancies of the prostate (Q35168184) (← links)
- An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers (Q35209855) (← links)
- Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients (Q35869335) (← links)
- Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer (Q36116069) (← links)
- Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA. (Q36116415) (← links)
- Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies (Q36258513) (← links)
- Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors (Q36423144) (← links)
- Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations (Q36590875) (← links)
- A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. (Q36626087) (← links)
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate (Q36641957) (← links)
- Prostate-specific antigen and prosttic acid phosphatase: Biomolecular and physiologic characteristics (Q36675822) (← links)